While Novartis and Bayer got there first, AstraZeneca, Bristol Myers Squibb and Eli Lilly are all vying to bring their ...
Researchers discovered peptides that permanently block a key cancer protein once thought untreatable, using a new screening ...
Korean researchers have developed an artificial intelligence (AI) model that can accurately predict the prognosis and ...
The first patient has been dosed with [212Pb]VMT01 in a phase 1/2a trial evaluating the safety of the agent in patients with ...
There were a number of notable developments for patients with kidney cancer at the symposium, Dr. Emre Yekedüz explained.